Evidence map›Paper›PMID 35911221›Full record

ArticleFrontiers in psychiatry2022

The course and determinants of post-traumatic stress over 12 months after hospitalization for COVID-19.

Knut Stavem, Trond Heir, Toril Dammen, Eivind Brønstad, Tøri Vigeland Lerum, Michael T Durheim, Kristine M A Lund, Bernt B Aarli, Gunnar Einvik

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Knut StavemDepartment of Pulmonary Medicine, Akershus University Hospital, Lørenskog, Norway.
Trond HeirInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Toril DammenInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Eivind BrønstadThoracic Department, St. Olavs Hospital, Trondheim, Norway.
Tøri Vigeland LerumInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Michael T DurheimInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Kristine M A LundDepartment of Infectious Diseases, Østfold Hospital Trust Kalnes, Grålum, Norway.
Bernt B AarliDepartment of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway.
Gunnar EinvikDepartment of Pulmonary Medicine, Akershus University Hospital, Lørenskog, Norway.
University of Oslo · NOAkershus University Hospital · NOOslo University Hospital · NOØstfold Hospital Trust · NOSt Olav's University Hospital · NOUniversity of Bergen · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To assess the trajectory of symptoms and symptom-defined post-traumatic stress disorder (PTSD) from 1.5 to 12 months after hospitalization for COVID-19 and determine risk factors for persistent symptoms and PTSD. Methods: This was a prospective cohort study of consecutive patients discharged after hospitalization for COVID-19 before 1 June 2020 in six hospitals in Southern Norway. Symptom-defined PTSD was assessed by the post-traumatic stress disorder (PTSD) checklist for DSM-5 (PCL-5) at 1.5, 3 and/or 12 months after hospitalization, using DSM-5 criteria. Changes in PCL-5 symptom score and the prevalence of PTSD were analyzed with multivariable mixed models. Results: In total, 388 patients were discharged alive, and 251 (65%) participated. Respondents had a mean (SD) age of 58.4 (14.2) years, and 142 (57%) were males. The prevalence of symptom-defined PTSD was 14, 8, and 9% at 1.5, 3, and 12 months, respectively. WHO disease severity for COVID-19 was not associated with PCL-5 scores. Female sex, lower age and non-Norwegian origin were associated with higher PCL-5 scores. The odds ratio (OR) (95%CI) for PTSD was 0.32 (0.12 to 0.83, Conclusions: The level of PTSD symptoms decreased from 1.5 to 3 months after hospitalization, but did not decrease further to 12 months, and there was no association between PTSD symptoms and COVID-19 disease severity.

Indexed as

cohortCOVID-19follow-upmedium-termPCL-5 questionnairepost-traumatic stress disorder (PTSD)

Identifiers

PMID35911221
PMCPMC9334651
OpenAlexW4285591526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.